The Market Reports

Synopsis

The global market for Man-made Vascular Graft was estimated to be worth US$ 4034 million in 2024 and is forecast to a readjusted size of US$ 5876 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.

Man-made Vascular Grafts are used to replace, bypass or maintain function of damaged, occluded or diseased blood vessels in small, medium and large diameter.

Expanding Market Size
With continuous advancements in medical technology and intensifying population aging, the market size for artificial blood vessels in China is also expanding steadily. It is estimated that the growth rate of the Chinese market will exceed the global average in the coming years.

Technological Innovation Driving Market Development
Application of New Materials: The field of artificial blood vessels is moving towards the direction of biodegradability, enhanced biocompatibility, and superior biomechanical properties. The application of biodegradable materials such as polylactic acid (PLA) and polycaprolactone (PCL) is expected to reduce the risks associated with long-term implantation in the body and improve patients' quality of life. The integration of nanotechnology has also brought new opportunities for enhancing the performance of artificial blood vessels. The application of nano-coatings and nano-fibers can enhance the blood vessels' antithrombotic capabilities, antibacterial properties, and durability, making artificial blood vessels safer and more reliable in clinical applications.

Advancements in Bioprinting Technology: Bioprinting allows for the manufacturing of artificial blood vessels with complex structures and functions, better matching the physiological characteristics of human blood vessels, thus improving surgical success rates and patients' recovery speeds. Additionally, bioprinting technology enables the customization of artificial blood vessels to meet the diverse needs of different patients and surgical procedures.

Intensifying Competition and Rising Market Concentration
Competition Among Domestic and Foreign Enterprises: With the entrance of both domestic and foreign enterprises, competition in the artificial blood vessel market is becoming increasingly fierce. Companies need to continuously reduce costs to maintain their competitiveness while increasing investments in innovation and research and development to create differentiated advantages.

Rising Market Concentration: The concentration of the Chinese artificial blood vessel market is relatively high, with major market participants occupying a significant market share. This concentration is reflected in diverse product lines, strong brand influence, and extensive market coverage. In the future, with intensifying market competition and industry consolidation, market concentration is expected to further increase.

Policies and Health Insurance Support Promoting Market Development
Policy Support: Government departments such as the National Development and Reform Commission have increased investments in medical services, promoting healthy capital flows for enterprises through policy support and accelerating industry development.

Health Insurance Coverage: The improvement of the health insurance system has made artificial blood vessel treatments more affordable for more patients, further driving the growth of market demand. In the future, with the expansion of health insurance coverage and optimization of reimbursement policies, the demand for artificial blood vessels is expected to further increase.

This report aims to provide a comprehensive presentation of the global market for Man-made Vascular Graft, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Man-made Vascular Graft by region & country, by Type, and by Application.

The Man-made Vascular Graft market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Man-made Vascular Graft.

Market Segmentation

By Company

• Getinge
• Bard PV
• Terumo
• W. L. Gore
• Japan Lifeline
• B.Braun
• LeMaitre Vascular
• Shanghai Chest Medical Instruments
• Aortec Medical Technology
• JIANGSU BIODA LIFE SCIENCE

Segment by Type

• ePTFE Man-made Vascular Graft
• Polyester Man-made Vascular Graft
• PTFE Man-made Vascular Graft
• Others

Segment by Application

• Aortic Disease
• Peripheral Artery Disease
• Hemodialysis

Segment by Region

• North America: United States, Canada, and Mexico
• Europe: United Kingdom, Germany, France, Spain, Italy, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, and Rest of Asia Pacific
• Middle East & Africa: Saudi Arabia, South Africa, and Rest of MEA
• Latin America: Brazil, Argentina, and Rest of Latin America

*If you need a regional or country-specific version, or customized segmentation, we can tailor the report to your requirements.